Department of Bariatric Surgery/Bariatric Medicine, Hamad General Hospital, 3050, Doha, Qatar.
Department of Surgery, Hamad General Hospital, 3050, Doha, Qatar.
Obes Surg. 2020 Apr;30(4):1219-1229. doi: 10.1007/s11695-019-04280-x.
Revisional gastric bypass (R-RYGB) surgery is utilized for the management of inadequate weight loss or weight regain observed after some cases of bariatric surgeries. Data on the mid-term effectiveness of primary gastric bypass (P-RYGB) compared with R-RYGB (e.g., post sleeve gastrectomy/gastric banding) are controversial.
Retrospective chart review of all patients who received P-RYGB and R-RYGB (January 2011-June 2015) at our center. One hundred twenty patients who underwent P-RYGB and 34 R-RYGB who completed 18 months follow-up were included. We compared the effectiveness of P-RYGB with R-RYGB by assessing four anthropometric, two glycemic, and four lipid parameters, as well as the control of type 2 diabetes (T2DM), hypertension, dyslipidemia (remission, improvement, persistence, relapse, de novo), mortality and complications rates.
A comparison of the effectiveness of P-RYGB with R-RYGB at 18 months revealed no significant differences in patients' age, gender, and preoperative BMI between groups. However, patients who received P-RYGB had lower mean weight (P = 0.001) and BMI (P < 0.001), reflected by a higher mean delta BMI (P = 0.02), total weight loss percentage (TWL%) (P < 0.0001) and excess weight loss percentage (EWL%) (P < 0.0001). No differences in glycemic parameters, lipid profiles, control of T2DM, hypertension, and dyslipidemia were observed. No death is reported and complication rates were comparable.
Although R-RYGB effectively addressed inadequate weight loss, weight regain, and recurrence of comorbidities after restrictive bariatric surgery, R-RYGB resulted in inferior weight loss compared with P-RYGB. Neither procedure differed in their clinical control of T2DM, hypertension, and dyslipidemia. Both procedures exhibited comparable complication rates.
减重手术后的再次手术(R-RYGB)用于治疗减重手术后出现的体重减轻不足或体重反弹。关于原发性胃旁路手术(P-RYGB)与 R-RYGB(例如胃袖状切除术/胃带术)相比的中期疗效数据存在争议。
对我院 2011 年 1 月至 2015 年 6 月期间接受 P-RYGB 和 R-RYGB 的所有患者进行回顾性病历分析。纳入了 120 例行 P-RYGB 和 34 例行 R-RYGB 且完成 18 个月随访的患者。我们通过评估四个人体测量学、两个血糖和四个血脂参数以及 2 型糖尿病(T2DM)、高血压、血脂异常(缓解、改善、持续、复发、新发)的控制情况,比较了 P-RYGB 和 R-RYGB 的疗效。
比较 18 个月时 P-RYGB 和 R-RYGB 的疗效,两组患者的年龄、性别和术前 BMI 无显著差异。然而,行 P-RYGB 的患者体重(P = 0.001)和 BMI(P < 0.001)均较低,平均 delta BMI(P = 0.02)、总减重百分比(TWL%)(P < 0.0001)和多余体重减轻百分比(EWL%)(P < 0.0001)均较高。血糖参数、血脂谱、T2DM、高血压和血脂异常的控制情况无差异。未报告死亡,并发症发生率相当。
尽管 R-RYGB 有效解决了限制型减重手术后体重减轻不足、体重反弹和合并症复发的问题,但与 P-RYGB 相比,R-RYGB 导致的体重减轻效果较差。两种手术在控制 T2DM、高血压和血脂异常方面没有差异。两种手术的并发症发生率相当。